Assert-IQ vs RhythmAnalytics

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

RhythmAnalytics

by Biofourmis Singapore Pte.

AI Verdict

Assert-IQ is a comprehensive insertable cardiac monitoring system that provides both long-term data collection via its device and subsequent arrhythmia detection. In contrast, RhythmAnalytics is an AI-powered cloud-based software designed to interpret cardiac arrhythmia data from various external FDA-cleared ECG devices. While both tools offer AI-driven arrhythmia detection for clinical decision support, Assert-IQ provides the full monitoring solution with its proprietary hardware, whereas RhythmAnalytics focuses solely on the analytical interpretation of externally sourced ECG data.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous, and discreet cardiac monitoring for patients with suspected, infrequent, or asymptomatic arrhythmias. This system is ideal for comprehensive arrhythmia detection over several years, providing remote monitoring capabilities and patient-activated symptom logging to aid in definitive diagnosis and management.

View Assert-IQ →

Choose RhythmAnalytics if…

Choose RhythmAnalytics if you require an AI-powered, automated interpretation of cardiac arrhythmias from single-lead ECG data for enhanced clinical decision support. This cloud-based API is best suited for healthcare professionals or integrators who need to quickly process and analyze ECG data from various FDA-cleared devices, enabling rapid detection of over 15 types of arrhythmias.

View RhythmAnalytics →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	RhythmAnalytics
Pricing	Enterprise	Contact vendor
Deployment	Hybrid	Cloud-based API
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Assert-IQ

Assert-IQ offers a more direct and comprehensive user experience for both patients and clinicians, including a patient-facing mobile app for symptom logging and remote monitoring, and remote programming capabilities for clinicians. RhythmAnalytics, being primarily an API, focuses on integration for developers, meaning its end-user usability is dependent on the systems it integrates with.

Clinical Value

Tie

Both tools offer substantial clinical value in cardiac arrhythmia management. Assert-IQ excels in long-term, continuous monitoring and reducing false positives in an insertable device. RhythmAnalytics provides highly accurate, automated interpretation of a wide range of arrhythmias from various single-lead ECG sources, demonstrating cardiologist-level performance.

Pricing & Value

Tie

Both Assert-IQ and RhythmAnalytics have opaque pricing models, requiring direct contact with the vendor for institutional or enterprise pricing. Neither tool offers a free trial, making it impossible to conduct a head-to-head comparison of their pricing and overall value without specific cost information.

Enterprise Readiness

RhythmAnalytics

RhythmAnalytics, with its cloud-based API deployment and SaaS offering, is inherently designed for seamless integration into diverse enterprise healthcare IT environments. While Assert-IQ is FDA-cleared and HIPAA compliant, its lack of an API might present integration challenges for some large health systems seeking deeper interoperability.

Innovation

Tie

Both tools showcase significant innovation in their respective domains. Assert-IQ's innovation lies in its extended battery life for continuous, long-term, and remote cardiac monitoring with AI-driven false positive reduction. RhythmAnalytics' innovation is in its highly accurate, AI-powered automated interpretation of a broad spectrum of arrhythmias from diverse single-lead ECG sources via an easily integratable API.

Support & Docs

Assert-IQ

Abbott, as a long-established medical device company, provides extensive and easily accessible documentation, including detailed manuals for clinicians and patients, and clear contact information for technical support. While Biofourmis offers a support intake form, the readily available and comprehensive nature of Assert-IQ's manuals and guides suggests a more robust and transparent support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	RhythmAnalytics
Name	Assert-IQ	RhythmAnalytics
Company	Abbott Medical	Biofourmis Singapore Pte.
Tagline	Advanced, long-term insertable cardiac monitoring for comprehensive arrhythmia detection.	AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support.
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	AI-based automated interpretation of cardiac arrhythmias, Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats), Beat-by-beat morphology computation, ECG signal processing and analysis, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis, Cloud-based API for integration, Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors)

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and RhythmAnalytics.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in how these tools acquire and process cardiac data?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system that provides long-term, continuous monitoring by being minimally invasively inserted into a patient. RhythmAnalytics is an AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data acquired from compatible FDA-cleared ECG devices like Holter or wearable sensors.

How do these tools differ in their integration capabilities with existing clinical workflows or other devices?

RhythmAnalytics offers a cloud-based API for integration with various FDA-cleared ECG devices. In contrast, Assert-IQ operates with a hybrid deployment model and does not have an API available for external integration.

What is the typical duration of monitoring or data analysis each tool provides?

Assert-IQ is designed for long-term continuous cardiac monitoring, capable of monitoring for up to 6 years. RhythmAnalytics provides automated interpretation of ECG data, with the duration of analysis depending on the input from compatible devices such as Holter or event recorders.

What specific types of arrhythmias can each tool detect or interpret?

RhythmAnalytics is specified to detect over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, with beat-by-beat morphology computation. Assert-IQ provides advanced arrhythmia detection algorithms for comprehensive arrhythmia detection.

How do these tools support patient engagement or interaction?

Assert-IQ includes a patient activator feature for symptom logging, allowing patients to record their symptoms. RhythmAnalytics focuses on the automated interpretation of ECG data for healthcare professionals and does not specify direct patient interaction features.

What is the primary clinical application or use case for each tool?

Assert-IQ is primarily used for diagnosing and managing patients with suspected heart rhythm disorders through long-term, continuous cardiac monitoring. RhythmAnalytics provides AI-powered automated interpretation of cardiac arrhythmias to offer clinical decision support for healthcare professionals.